Effect of the COVID-19 pandemic on acute stroke reperfusion therapy: data from the Lyon Stroke Center Network.
Cécile PlumereauTae-Hee ChoMarielle BuissonCamille AmazMatteo CappucciLaurent DerexElodie OngJulia FontaineLucie RascleRoberto RivaDavid SchiavoAxel BenhamedMarion DouplatThomas BonyKarim TazarourteCélia TuttleOmer Faruk EkerYves BerthezèneMichel OvizeNorbert NighoghossianLaura MechtouffPublished in: Journal of neurology (2020)
Our study showed a decrease in the volume of IVT, whereas the volume of MT remained stable although intra-hospital delays increased for transferred patients during the COVID-19 pandemic. These results contrast in part with the national surveys and suggest that the impact of the pandemic may depend on local stroke care networks.
Keyphrases
- end stage renal disease
- atrial fibrillation
- healthcare
- ejection fraction
- cerebral ischemia
- quality improvement
- newly diagnosed
- chronic kidney disease
- sars cov
- coronavirus disease
- magnetic resonance
- peritoneal dialysis
- acute myocardial infarction
- prognostic factors
- electronic health record
- computed tomography
- machine learning
- cross sectional
- patient reported outcomes
- blood brain barrier
- percutaneous coronary intervention
- pain management
- brain injury
- contrast enhanced
- replacement therapy